The survey indicates that doctors are worried about the abolition of second vaccination
In the midst of concerns from medical associations regarding policies to expand the distance between injections and the danger to medical practitioners and their patients if they are not adequately covered, doctors get their second dose of the Covid vaccine late.
A survey of doctors around the UK by advocacy group Everydoctor found that doctors who got their first dose of the Covid vaccine in several areas have since cancelled their second dose appointments.
Last Wednesday, the government announced that it is updating its vaccination strategy to increase the period from the recommended three to four weeks between delivering the two doses to 12 weeks, as it makes frontline health and care staff a key vaccination focus category.
Instead of giving half the individuals full immunity with two vaccines, the move aims to give as many individuals as possible some immunity with one vaccine.
However, physician associations and patients expressed frustration with the policy, which culminated in the cancelation of their booked second appointments by several hundreds of thousands of individuals.
While there is evidence from Oxford/AstraZeneca vaccine research, which started delivery on Monday, that people who got the second injection later are more effective, Pfizer/BioNTech said that there is no evidence that a single shot of their vaccine is effective after three weeks.
Everydoctor’s director, Dr. Julia Patterson, said doctors are worried that delaying the second dose they need to achieve maximum immunity could cause them to get sick or infect peers or patients.
175 (13 percent) said they had received one dose of the Covid vaccine in a self-selecting survey of 1,318 doctors, but the appointment for their second dose – booked when they received their first injection – has since been cancelled.
Another 517 (39 percent) said that they were still not told when their first dose would be given.
The crisis of Covid 19 is escalating, and we desperately need to protect those on the front lines who operate.
They are at risk themselves while health care staff are unprotected and can also transmit the coronavirus to vulnerable patients, Patterson said.
“We were pleased last week that health care workers will now be prioritized for vaccination. However, five days later, many staff are still in the dark about when they will be vaccinated.” Hospitals can now concentrate on vaccinating as many employees as soon as both vaccine supplies enable, she added.
Just 388 (30%) of doctors said they obtained their first dose and would receive their second dose as expected, irrespective of the shift in approach.
Karoline Lamb, 84, said she was “absolutely angry” that she did not get the second dose of the Pfizer vaccine: “I was so excited when I got the first dose.”
I didn’t have any side effects, and on January 21, I signed up for a second dose, but I’m very nervous it would be cancelled,’ said Lamb, from Buckinghamshire’s Chalfont St Giles. “If I don’t get the second dose within three weeks, I’m worried that the first dose could do more harm than good. If I had known the government wouldn’t get me the second dose in time, I wouldn’t have taken the first dose.”
In the meantime, after being checked by medical authorities, almost 3.5 million doses of the Oxford vaccine are waiting for publication, the Guardian has heard, in the midst of demands to speed up the introduction of vaccination in what the Labour Party called a “race against time.” The government said, 530,000 doses are to be administered earlier this week.
It is estimated that several million more doses of the vaccine were produced in the U.K. but have not yet been filled into vials.
Starting next week, the NHS must deliver at least 2 million vaccinations a week if it is to fulfill the initiative of Boris Johnson to vaccinate all in the four highest priority groups by mid-February. According to Nadhim Zahawi, the Minister of Vaccines, the four groups the prime minister said would receive a first dose of 13.9 million people in England.
Pascal Soriot, AstraZeneca’s chief executive, said Dec. 30 that his company will be able to supply 2 million doses a week to